Fitaro 0.5 mg/0.5 ml (SC Injection)
0.5 mg pre-filled syringe: ৳ 700.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Semaglutide |
| Company | Incepta pharmaceuticals ltd |
| Also available as |
Title
- Fitaro Tablet
- Semaglutide
Categories
- Medicine
- Pharmaceutical
Description
- Indicated for diabetes mellitus
- Also used for obesity management
- GLP-1 receptor agonist
Color Options
- N/A
Functions
- Blood glucose control
- Reduction of major adverse cardiovascular events
- Weight management
Materials
- N/A
Technical Specifications
- Tablet form
- Subcutaneous injection
- Different dosages available
- Storage at 2-8°C
Design Elements
- Pharmacological action similar to human GLP-1
- Reduces body weight and fat mass
- Delays gastric emptying
Usability Features
- Once daily or once weekly administration
- Dose adjustment for different patient needs
- Ease of storage
Dimensions
- N/A
Dosage & Administration
- Starter Dose: 3 mg once daily for 30 days
- Maintenance Dose: 7 mg once daily
- For Additional Glycemic Control: Dose can be increased to 14 mg once daily
- Starting dose for obesity: 0.25 mg once weekly for 4 weeks
Interaction
- Delays gastric emptying and may impact absorption of concomitantly administered oral medications
Contraindications
- Hypersensitivity to the active substance or excipients
Side Effects
- Possible hypoglycemia when used with insulin or sulfonylurea
- Common adverse reactions: gastrointestinal disorders, nausea, diarrhea, vomiting, abdominal pain, constipation
Pregnancy & Lactation
- Should not be used during pregnancy or breastfeeding
Precautions & Warnings
- Not for use in type 1 diabetes mellitus or diabetic ketoacidosis
- Discontinue promptly if pancreatitis is suspected
- Monitor patients with diabetic retinopathy
Use in Special Populations
- Safety and efficacy in children and adolescents not established
- No dose adjustment based on age or renal impairment
- Not recommended for use in end-stage renal disease
Overdose Effects
- Reported overdose up to 4 mg in a single dose and up to 4 mg in a week
- Nausea most commonly reported adverse reaction
- No specific antidote
- Dose adjustment when added to existing therapy
Therapeutic Class
- GLP-1 receptor agonists
Storage Conditions
- Store at 2-8°C in a refrigerator
- Do not freeze
- Keep out of reach of children